ST3 beta-Galactoside alpha-2,3-Sialyltransferase 5 (ST3GAL5) ELISA Kits

Ganglioside GM3 is known to participate in the induction of cell differentiation, modulation of cell proliferation, maintenance of fibroblast morphology, signal transduction, and integrin-mediated cell adhesion. Zusätzlich bieten wir Ihnen ST3 beta-Galactoside alpha-2,3-Sialyltransferase 5 Antikörper (36) und ST3 beta-Galactoside alpha-2,3-Sialyltransferase 5 Proteine (8) und viele weitere Produktgruppen zu diesem Protein an.

list all ELISA KIts Gen GeneID UniProt
Anti-Human ST3GAL5 ST3GAL5 8869 Q9UNP4
Anti-Maus ST3GAL5 ST3GAL5 20454 O88829
Anti-Ratte ST3GAL5 ST3GAL5 83505 Q68G12
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen

Weitere ELISA Kits für ST3 beta-Galactoside alpha-2,3-Sialyltransferase 5 Interaktionspartner

Human ST3 beta-Galactoside alpha-2,3-Sialyltransferase 5 (ST3GAL5) Interaktionspartner

  1. While no differences in clinical characteristics were detected in patients possessing the functional promoter haplotypes of ST3GAL5, exophthalmic values were significantly lower in patients with the ST8SIA1 (zeige ST8SIA1 ELISA Kits) haplotype, which showed a significant increase in promoter activity

  2. These cases broaden the phenotypic and genetic spectrum of GM3 synthase deficiency due to ST3GAL5 variants. Patients with intellectual disability or furthermore presenting with Rett-like phenotype should be suspected of GM3 synthase deficiency, a disorder of ganglioside biosynthesis.

  3. Data suggest that ganglioside glycosyltransferases ST3GAL5, ST8SIA1 (zeige ST8SIA1 ELISA Kits), and B4GALNT1 (zeige B4GALNT1 ELISA Kits) are S-acylated at conserved cysteine residues located close to cytoplasmic border of their transmembrane domains; ST3Gal-II (zeige ST3GAL2 ELISA Kits) is acylated at conserved cysteine residue in N-terminal cytoplasmic tail; for B4GALNT1 (zeige B4GALNT1 ELISA Kits) and ST3Gal-II (zeige ST3GAL2 ELISA Kits), dimer formation controls their S-acylation status.

  4. Studied the miRNA expression in human hepatocellular carcinoma cell lines; 13 differentially expressed miRNAs were identified between MHCC97-H and MHCC97-L cells; and the same results were found in clinical samples. Found that ST3GAL5 was the direct target of miR (zeige MLXIP ELISA Kits)-26a, miR (zeige MLXIP ELISA Kits)-548l and miR (zeige MLXIP ELISA Kits)-34a.

  5. Serum deprivation triggers upregulation of hST3Gal V gene expression through Runx2 activation by BMP signaling in MG-63 cells.

  6. this study indicated that sialylation involved in the development of MDR of AML (zeige RUNX1 ELISA Kits) cells probably through ST3GAL5 or ST8SIA4 (zeige ST8SIA4 ELISA Kits) regulating the activity of PI3K (zeige PIK3CA ELISA Kits)/Akt (zeige AKT1 ELISA Kits) signaling and the expression of P-gp (zeige ABCB4 ELISA Kits) and MRP1 (zeige MDM4 ELISA Kits).

  7. Whole-exome sequencing of patients with salt and pepper syndrome shows a homozygous c.994G>A transition (p.E332K) in the ST3GAL5 gene.

  8. GM3 synthase deficiency, responsible for early-onset epilepsy syndrome, leads to a secondary respiratory chain dysfunction.

  9. Data demonstrate that valproic acid (VPA) transcriptionally regulates human GM3 synthase (hST3Gal V), which catalyzes ganglioside GM3 (zeige GRM6 ELISA Kits) biosynthesis in ARPE-19 human retinal pigment epithelial cells.

  10. GM3 (zeige GRM6 ELISA Kits) exhibits the potential to regulate the allosteric structural transition from inactive to a signaling EGFR (zeige EGFR ELISA Kits) dimer, by preventing the autophosphorylation of the intracellular kinase (zeige GSK3b ELISA Kits) domain in response to ligand binding

Mouse (Murine) ST3 beta-Galactoside alpha-2,3-Sialyltransferase 5 (ST3GAL5) Interaktionspartner

  1. We used GM2/GD2 synthase (B4galnt1 (zeige B4GALNT1 ELISA Kits))-deficient mice to immunize by liposomes embedded with GD1alpha or acidic glycolipid fractions from brain of St3gal5-deficient mice. Specificities of established mAbs as analyzed by enzyme-linked immunosorbent assay and thin-layer chromatography-immunostaining were very high among various gangliosides.

  2. These studies establish ganglioside GM3 (zeige GRM6 ELISA Kits) as a new candidate responsible for neuropathic pain and small fiber neuropathy in diabetes.

  3. Functionally, the repression of St3gal5 suffices to elevate intercellular adhesion and expression of distinct junction-associated proteins, reminiscent of knockdown of Zeb1 (zeige ZEB1 ELISA Kits).

  4. ganglioside GM3 synthase has a role in siRNA-based spherical nucleic acid reversal of impaired wound healing in diabetic mice

  5. Results show that complete and partial deletion of the GM3 synthase gene exert distinct effects on the NP-C (Niemann-Pick disease Type C) phenotype.

  6. genes involved in the sphingolipids metabolism may be modifiers of cystogenesis, and suggest GM3 synthase as a new anti-cystic therapeutic target.

  7. Results suggest that complete, but not partial, inhibition of GM3 (zeige GRM6 ELISA Kits) synthesis results in robust activation of an alternate pathway that may compensate for the complete absence of the products of GM3 synthase.

  8. the age at death of the npc1 (zeige NPC1 ELISA Kits)(-/-) mouse can be significantly influenced by many factors, including differences in strain background, other inactivating gene mutations in Siat9 and lxrbeta (zeige NR1H2 ELISA Kits)

  9. GM3 synthase silencing suppressed lung metastasis in murine breast cancer cells. The molecular mechanism that underlies GM3 synthase mediated migration and invasion was inhibition of the phosphoinositide-3 kinase/Akt (zeige AKT1 ELISA Kits) pathway.

  10. The defect of hearing ability of GM3 synthase null mice could be attributed to the functional disorganization of the organ of Corti, and the expression of gangliosides, especially GM3 (zeige GRM6 ELISA Kits), during the maturation of the cochlea.

ST3 beta-Galactoside alpha-2,3-Sialyltransferase 5 (ST3GAL5) Antigen-Profil

Beschreibung des Gens

Ganglioside GM3 is known to participate in the induction of cell differentiation, modulation of cell proliferation, maintenance of fibroblast morphology, signal transduction, and integrin-mediated cell adhesion. The protein encoded by this gene is a type II membrane protein which catalyzes the formation of GM3 using lactosylceramide as the substrate. The encoded protein is a member of glycosyltransferase family 29 and may be localized to the Golgi apparatus. Mutation in this gene has been associated with Amish infantile epilepsy syndrome. Transcript variants encoding different isoforms have been found for this gene.

Genbezeichner und Symbole assoziert mit ST3GAL5

  • ST3 beta-galactoside alpha-2,3-sialyltransferase 5 (ST3GAL5) Antikörper
  • ST3 beta-galactoside alpha-2,3-sialyltransferase 5 (St3gal5) Antikörper
  • 3S-T Antikörper
  • SATI Antikörper
  • Siat9 Antikörper
  • SIATGM3S Antikörper
  • ST3GAL-V Antikörper
  • ST3GalV Antikörper
  • [a]2 Antikörper

Bezeichner auf Proteinebene für ST3GAL5

CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase , GM3 synthase , ST3Gal V , alpha 2,3-sialyltransferase V , ganglioside GM3 synthase , lactosylceramide alpha-2,3-sialyltransferase , sialyltransferase 9 (CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase; GM3 synthase) , ST3GalV , alpha2,3-sialyltransferase , sialyltransferase 9 , GM3-specific sialytransferase , mST3Gal V , sialyltransferase 9 (CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase)

8869 Homo sapiens
612022 Canis lupus familiaris
404164 Bos taurus
20454 Mus musculus
83505 Rattus norvegicus
Haben Sie etwas anderes gesucht?